Published in Int J Tuberc Lung Dis on February 01, 2008
New diagnostic methods for tuberculosis. Curr Opin Infect Dis (2009) 1.40
IP-10 detection in urine is associated with lung diseases. BMC Infect Dis (2010) 1.05
Implications of storing urinary DNA from different populations for molecular analyses. PLoS One (2009) 1.00
Exploring alternative biomaterials for diagnosis of pulmonary tuberculosis in HIV-negative patients by use of the GeneXpert MTB/RIF assay. J Clin Microbiol (2013) 0.99
Detection of soluble antigen and DNA of Trypanosoma cruzi in urine is independent of renal injury in the guinea pig model. PLoS One (2013) 0.90
A salting out and resin procedure for extracting Schistosoma mansoni DNA from human urine samples. BMC Res Notes (2010) 0.87
Transformative tools for tackling tuberculosis. J Exp Med (2015) 0.87
A magnetic bead-based method for concentrating DNA from human urine for downstream detection. PLoS One (2013) 0.85
Use of transrenal DNA for the diagnosis of extrapulmonary tuberculosis in children: a case of tubercular otitis media. J Clin Microbiol (2014) 0.85
Long-term frozen storage of urine samples: a trouble to get PCR results in Schistosoma spp. DNA detection? PLoS One (2013) 0.83
Tuberculosis Biomarkers: From Diagnosis to Protection. Infect Dis Rep (2016) 0.80
Development and evaluation of an in-house single step loop-mediated isothermal amplification (SS-LAMP) assay for the detection of Mycobacterium tuberculosis complex in sputum samples from Moroccan patients. BMC Infect Dis (2016) 0.75
Design and use of mouse control DNA for DNA biomarker extraction and PCR detection from urine: Application for transrenal Mycobacterium tuberculosis DNA detection. J Microbiol Methods (2017) 0.75
Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine. PLoS One (2015) 0.75
Urine PCR evaluation to diagnose pulmonary tuberculosis. Jundishapur J Microbiol (2014) 0.75
Diagnostic accuracy of nucleic acid amplification tests in urine for pulmonary tuberculosis: a meta-analysis. Int J Tuberc Lung Dis (2015) 0.75
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med (1997) 7.11
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J (2010) 4.72
Prophylaxis after occupational exposure to HIV. BMJ (1997) 4.07
Measles outbreak on a cruise ship in the western Mediterranean, February 2014, preliminary report. Euro Surveill (2014) 3.87
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr (2001) 3.83
Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J (2010) 3.81
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J (2009) 3.16
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis. Eur Respir J (2009) 2.92
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ (2005) 2.91
Late presentation of HIV infection: a consensus definition. HIV Med (2011) 2.67
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J (2010) 2.56
Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem (2000) 2.53
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy. J Infect Dis (2001) 2.50
Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature (1995) 2.48
Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis (2003) 2.47
Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J (2007) 2.46
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat Med (1999) 2.27
Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 2.24
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. Eur Respir J (2008) 2.23
Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax (2006) 2.20
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood (1999) 2.10
Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA (1995) 2.08
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur Respir J (2009) 2.07
Cytotoxic necrotizing factor production by hemolytic strains of Escherichia coli causing extraintestinal infections. J Clin Microbiol (1987) 2.07
The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ (2008) 2.01
The genetic program of cell death. Hypothesis and some applications: transformation, carcinogenesis, ageing. J Theor Biol (1982) 1.97
SARPs: a family of secreted apoptosis-related proteins. Proc Natl Acad Sci U S A (1997) 1.84
Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS (2000) 1.82
Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis (2001) 1.77
Apoptosis: molecular mechanisms in programmed cell death. Eur J Cell Biol (1991) 1.74
HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. Proc Natl Acad Sci U S A (1996) 1.67
Apoptosis in human skin development: morphogenesis, periderm, and stem cells. Dev Dyn (1994) 1.64
Two-dimensional echocardiographic features of echinococcosis of the heart and great blood vessels. Clinical and surgical implications. Circulation (1988) 1.56
Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. AIDS (2000) 1.52
Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion. Am J Pathol (1997) 1.52
The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats. Clin Microbiol Infect (2009) 1.52
Mechanisms of apoptosis induction by the HIV-1 envelope. Cell Death Differ (2005) 1.52
'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ (2002) 1.49
Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J Exp Med (2001) 1.47
Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem (1997) 1.46
Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin Microbiol Infect (2006) 1.45
Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes. Proc Natl Acad Sci U S A (1996) 1.43
Prevalence of hepatitis B and C viruses and human immunodeficiency virus infections in women of reproductive age. Br J Obstet Gynaecol (1992) 1.41
Diagnostic accuracy of in-house PCR for pulmonary tuberculosis in smear-positive patients: meta-analysis and metaregression. J Clin Microbiol (2009) 1.40
High-fat versus high-carbohydrate enteral formulae: effect on blood glucose, C-peptide, and ketones in patients with type 2 diabetes treated with insulin or sulfonylurea. Nutrition (1999) 1.40
[Variable response to the biological inhibition of platelets by abciximab in patients subjected to percutaneous coronary angioplasty]. Rev Esp Cardiol (2001) 1.40
Pulmonary tuberculosis in HIV-infected patients presenting with normal chest radiograph and negative sputum smear. Infection (2002) 1.39
Clustered cases of pneumonia among healthcare workers over a 1-year period in three Italian hospitals: applying the WHO SARS alert. Infection (2006) 1.39
SARS and masks. J Hosp Infect (2004) 1.39
Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57. Br J Cancer (2007) 1.39
The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FEBS Lett (1992) 1.38
AIDS in Italy. Lancet (1984) 1.38
Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol Cell Biol (1994) 1.37
Estimating diagnostic accuracy of tests for latent tuberculosis infection without a gold standard among healthcare workers. Euro Surveill (2009) 1.35
Risk of hepatitis C seroconversion after occupational exposures in health care workers. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. Am J Infect Control (1995) 1.34
Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Defic Syndr (2001) 1.31
Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls. Clin Microbiol Infect (2009) 1.29
Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur Respir J (2009) 1.27
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P). Vaccine (2001) 1.26
Apoptosis and its role in human disease. Biotechnology (N Y) (1994) 1.25
Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. J Acquir Immune Defic Syndr (2001) 1.24
Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin. Cell Death Differ (2007) 1.23
Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS (2000) 1.23
A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study. Breast Cancer Res Treat (2012) 1.22
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy. Eur Respir J (2004) 1.21
Letter to the editor: management of patients with Ebola virus disease in Europe: high-level isolation units should have a key role. Euro Surveill (2014) 1.21
Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection. J Pathol (1997) 1.21
Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS (1994) 1.20
European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus. Euro Surveill (2005) 1.20
Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett (1989) 1.19
Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res (1997) 1.19
Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion. J Cell Biol (1992) 1.17
Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study. Clin Exp Immunol (2007) 1.16
Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development (1993) 1.15
'Tissue' transglutaminase in cell death: a downstream or a multifunctional upstream effector? FEBS Lett (1998) 1.15
Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol Cell Biol (1997) 1.15
QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J (2008) 1.13
Conjoined lumbosacral nerve roots: observations on three cases and review of the literature. Neurocirugia (Astur) (2006) 1.12
Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int J STD AIDS (2004) 1.12
Circulating nucleic acids and apoptosis. Ann N Y Acad Sci (2001) 1.11